These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 7902022

  • 41. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis.
    Kidd M, McKenzie SH, Steven I, Cooper C, Lanz R, Australian Ketotifen Study Group.
    Br J Ophthalmol; 2003 Oct; 87(10):1206-11. PubMed ID: 14507747
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. An efficacy and tolerance comparison of emedastine difumarate 0.05% and levocabastine hydrochloride 0.05%: reducing chemosis and eyelid swelling in subjects with seasonal allergic conjunctivitis. Emadine Study Group.
    Secchi A, Leonardi A, Discepola M, Deschenes J, Abelson MB.
    Acta Ophthalmol Scand Suppl; 2000 Oct; (230):48-51. PubMed ID: 11057351
    [Abstract] [Full Text] [Related]

  • 45. Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group.
    Richard C, Trinquand C, Bloch-Michel E.
    Eur J Ophthalmol; 1998 Oct; 8(4):207-16. PubMed ID: 9891891
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
    Falser N, Wober W, Rahlfs VW, Baehre M.
    Arzneimittelforschung; 2001 Oct; 51(5):387-93. PubMed ID: 11413739
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Efficacy of levocabastine in conjunctival provocation studies.
    Janssens M.
    Doc Ophthalmol; 1992 Oct; 82(4):341-51. PubMed ID: 1363980
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Twice daily 4% Sodium Cromoglycate vs. 2% Sodium Cromoglycate used four times daily in seasonal (grass pollen) allergic conjunctivitis.
    Collum LM, Fitzsimon S, Hillery M, Collum A, Power WJ, Pelikan Z, Jenson JB.
    Doc Ophthalmol; 1992 Oct; 82(3):267-77. PubMed ID: 1303863
    [Abstract] [Full Text] [Related]

  • 57. [Safety and efficacy of a new preservative-free levocabastine ophthalmic solution (Levofree®) using the conjunctival provocation test].
    Allaire C, Siou-Mermet R, Bassols A.
    J Fr Ophtalmol; 2012 Sep; 35(7):491-8. PubMed ID: 22498504
    [Abstract] [Full Text] [Related]

  • 58. Randomised double masked trial comparing the efficacy and tolerance of 0.05% mequitazine eye drops versus 0.05% levocabastine and placebo in allergic conjunctivitis induced by a conjunctival provocation test with Dermatophagoides pteronyssinus.
    Mortemousque B, Jacquet A, Richard C, Depont F, Colin J, Moore N.
    Br J Ophthalmol; 2004 Mar; 88(3):336-40. PubMed ID: 14977764
    [Abstract] [Full Text] [Related]

  • 59. Inhibitory effect of levocabastine on experimental allergic conjunctivitis in guinea pigs.
    Kamei C, Izushi K, Tasaka K.
    J Pharmacobiodyn; 1991 Aug; 14(8):467-73. PubMed ID: 1723098
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.